CIBC Asset Management
MDCO

CIBC Asset Management’s Medicines Co MDCO Stock Holding History

CIBC Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,957
Closed -$251K – 1193
2019
Q4 		$251K Sell
2,957
-1,273
-30% -$84.9K ﹤0.01% 953
2019
Q3 		$212K Buy
+4,230
New +$169K ﹤0.01% 1001
2018
Q3 		– Sell
-5,709
Closed -$210K – 1169
2018
Q2 		$210K Buy
+5,709
New +$186K ﹤0.01% 1022
2017
Q4 		– Sell
-6,296
Closed -$233K – 1102
2017
Q3 		$233K Buy
6,296
+163
+3% +$6.01K ﹤0.01% 903
2017
Q2 		$233K Hold
6,133
– – ﹤0.01% 864
2017
Q1 		$300K Hold
6,133
– – ﹤0.01% 786
2016
Q4 		$208K Buy
+6,133
New +$218K ﹤0.01% 894
2015
Q4 		– Sell
-5,500
Closed -$209K – 957
2015
Q3 		$209K Buy
+5,500
New +$193K ﹤0.01% 848

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

CIBC Asset Management's MDCO Position: Q1 2020 in Review

CIBC Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 2,957 shares — an estimated $251K sold.

CIBC Asset Management first reported a position in MDCO in Q3 2015 and held it in 8 quarters. The position peaked at $300K in Q1 2017. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • CIBC Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • CIBC Asset Management sold 2,957 Medicines Co shares in Q1 2020, an estimated $251K.
  • CIBC Asset Management first reported a position in Medicines Co in Q3 2015 and held it in 8 quarters.
  • CIBC Asset Management's Medicines Co position peaked at $300K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on CIBC Asset Management's 13F filing for Q1 2020, filed 30 Apr 2020.